Access cutting-edge kidney cancer treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access kidney cancer specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancer treatment provided free
The primary objective of this study is to evaluate whether the combination of Pembrolizumab and Axitinib given in the neoadjuvant setting can change the Inferior Vena Cava Tumor Thrombus burden. A decrease in the size of the tumor thrombus can potentially lead to decrease in surgical complications, improve patient related health outcomes, and improve long term outcomes such as progression free survival and overall survival.
Sponsor: University of Colorado, Denver
Check if you qualify for this kidney cancer clinical trial in Aurora, CO
If you're searching for kidney cancer treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.